News about Quality / GMP

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Quality / GMP | 18/07/2023 | By Sudeep Soparkar 527

Gland Pharma Limited - Conclusion of US FDA Inspection at Dundigal Facility, Hyderabad

Gland Pharma Limited - Conclusion of US FDA Inspection at Dundigal Facility, Hyderabad

Gland Pharma Limited - Conclusion of US FDA Inspection at Dundigal Facility, Hyderabad

Quality / GMP | 17/07/2023 | By Sudeep Soparkar 860

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Quality / GMP | 13/07/2023 | By Sudeep Soparkar 750

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

Quality / GMP | 10/07/2023 | By Sudeep Soparkar 1209

Zydus receives EIR from the USFDA for its SEZ 1 manufacturing facility at Pharmez, Ahmedabad

Zydus receives EIR from the USFDA for its SEZ 1 manufacturing facility at Pharmez, Ahmedabad

Zydus receives EIR from the USFDA for its SEZ 1 manufacturing facility at Pharmez, Ahmedabad

Quality / GMP | 06/07/2023 | By Sudeep Soparkar 940

Quality / GMP | 06/07/2023 | By Sudeep Soparkar 566

US FDA Inspection at Pashmylaram Facility, Hyderabad of Gland Pharma Ltd

US FDA Inspection at Pashmylaram Facility, Hyderabad of Gland Pharma Ltd

US FDA Inspection at Pashmylaram Facility, Hyderabad of Gland Pharma Ltd

Quality / GMP | 28/06/2023 | By Sudeep Soparkar 762

Ipca Laboratories Ltd receives 8 observations from USFDA for formulations facility at SEZ Indore, Pithampur

Ipca Laboratories Ltd receives 8 observations from USFDA for formulations facility at SEZ Indore, Pithampur

Ipca Laboratories Ltd receives 8 observations from USFDA for formulations facility at SEZ Indore, Pithampur

Quality / GMP | 26/06/2023 | By Sudeep Soparkar 1552

Gufic receives approval from NMPA, China for Prilocaine API

Gufic receives approval from NMPA, China for Prilocaine API

Gufic receives approval from NMPA, China for Prilocaine API

Quality / GMP | 19/06/2023 | By Sudeep Soparkar 477

NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine for the US market

NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine for the US market

NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine for the US market

Quality / GMP | 19/06/2023 | By Sudeep Soparkar 770

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members